Life-years-gained from population risk factor changes and modern cardiology treatments in Ireland

European Journal of Public Health

Volumn 17, Issue 2, 2007, Pages 193-198

  Kabir, Zubair ^a   Bennett, Kathleen ^a   Shelley, Emer ^b   Unal, Belgin ^c   Critchley, Julia ^d   Feely, John ^a   Capewell, Simon ^e  

^a ST JAMES S HOSPITAL   (Ireland)

^b Department of Health and Children ^*  (Ireland)

^c DOKUZ EYLUL UNIVERSITY   (Turkey)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

^e UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Coronary heart disease; Ireland; Life years gained; Risk factors; Treatments

Indexed keywords

CHOLESTEROL;

ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; ATTITUDE TO LIFE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DIETARY INTAKE; FEMALE; HEALTH CARE POLICY; HEALTH PROMOTION; HEART PROTECTION; HUMAN; IRELAND; ISCHEMIC HEART DISEASE; LIFE EXPECTANCY; LIFESPAN; MALE; OBESITY; POPULATION RISK; PRIORITY JOURNAL; RISK FACTOR; SECONDARY PREVENTION; SENSITIVITY ANALYSIS; SMOKING; SMOKING CESSATION; SURVIVAL RATE; SURVIVAL TIME; VALIDATION STUDY; WEIGHT REDUCTION;

ADULT; AGED; AGED, 80 AND OVER; CORONARY DISEASE; FEMALE; HEALTH BEHAVIOR; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; IRELAND; MALE; MIDDLE AGED; MODELS, CARDIOVASCULAR; OBESITY; QUALITY-ADJUSTED LIFE YEARS; RISK ASSESSMENT; RISK FACTORS; RISK REDUCTION BEHAVIOR; SMOKING; SURVIVAL ANALYSIS;

EID: 34047194920     PISSN: 11011262     EISSN: 1464360X     Source Type: Journal    
DOI: 10.1093/eurpub/ckl090     Document Type: Article

References (39)

1. Codd MB (ed). 50 years of Heart Disease in Ireland. Dublin: Irish Heart Foundation, 2001.
2. Critchley J, Capewell S. Why model coronary heart disease? Eur Heart J 2002;23:110-6.
3. Capewell S, Beaglehole R, Seddon M, McMurray J. Explaining the decline in Coronary Heart Disease Mortality in Auckland, New Zealand between 1982 and 1993. Circulation 2000;102:1511-6.
4. Hunink MG, Goldman L, Tosteson, et al. The recent decline in mortality from coronary heart disease, 1980-1990 The effect of secular trends in risk factors and treatment. JAMA 1997;277:535-42.
5. Laatikainen T, Critchley J, Vartiainen E, et al. Explaining the decline in coronary heart disease mortality in Finland between 1982 and 1997. Am J Epidemiol 2005;162:764-73.
6. Capewell S, Morrison CE, McMurray JJ. Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994. Heart 1999;81:380-6.
7. Unal B, Critchley J, Capewell S. Explaining the decline in coronary heart disease mortality in England and Wales, 1981-2000. Circulation 2004;109:1101-7.
8. Bennett K, Kabir Z, Unal B, et al. Explaining the recent decline in coronary heart disease mortality in Ireland 1985-2000. J Epidemiol Community Health 2006;60:322-7.
9. Central Statistics Office, Dublin Ireland. Available at: www.cso.ie (accessed 31 March 2006).
10. Unal B, Critchley JA, Fidan D, Capewell S. Life-years gained from modern cardiological treatments and population risk factor changes in England and Wales, 1981-2000. Am J Pub Health 2005;95:103-8.
11. Critchley JA, Capewell S, Unal B. Life-years gained from coronary heart disease mortality reduction in Scotland: prevention or treatment? J Clin Epidemiol 2003;56:583-90.
12. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): a case-control study. Lancet 2004;364:937-52.
13. The IMPACT Model website. Available at: http://www.liv.ac.uk/ PublicHealth/sc/bua/IMPACT-Model-Appendices.pdf.
14. Law MR, Wald NJ, Thompson SG. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ 1994;308:367-72.
15. Lonergan M (ed). Irish Cardiac Surgery Register Report 1983-2001. Ireland: Irish Cardiac Surgery Group, 2002.
16. Pell JP, MacIntyre K, Walsh D, et al. Time trends in survival and readmission following coronary artery bypass grafting in Scotland, 1981-96: retrospective observational study. BMJ 2002;324:201-2.
17. Pocock SJ, Henderson RA, Rickards AF, et al. Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery. Lancet 1995;346:1184-9.
18. Pate GE, Curtin R, Talbot A, et al. Audit of acute myocardial infarctions at Saint James's Hospital, Dublin from 1996 to 1999. Ir Med J 2002;95:274-6.
19. Capewell S, Livingston BM, MacIntyre K, et al. Trends in case-fatality in 117 718 patients admitted with acute myocardial infarction in Scotland. Eur Heart J 2000;21:1833-40.
20. MacIntyre K, Capewell S, Stewart S, et al. Evidence of improving prognosis in heart failure. Trends in case fatality in 66 547 patients hospitalized between 1986 and 1995. Circulation 2000;102:1126-31.
21. Isles CG, Walker LM, Beevers GD, et al. Mortality in patients of the Glasgow Blood Pressure Clinic. J Hypertens 1986;4:141-56.
22. Tsevat J, Weinstein MC, Williams LW, et al. Expected gains in life expectancy from various coronary heart disease risk factor modifications. Circulation 1991;83:1194-201.
23. Yudkin JS. How can we best prolong life? Benefits of coronary risk factor reduction in non-diabetic and diabetic subjects. BMJ 1993;306:1313-8.
24. Briggs A, Sculpher M, Buxton M. Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis. Health Econ 1994;3:95-104.
25. Grover SA, Paquet S, Levinton C, et al. Estimating the benefits of modifying risk factors of cardiovascular disease: a comparison of primary vs secondary prevention. Arch Intern Med 1998;158:655-62.
26. Bunker JP. The role of medical care in contributing to health improvements within societies. Int J Epidemiol 2001;30:1260-3.
27. Shelley E, Daly L, Collins C, et al. Cardiovascular risk factor changes in the Kilkenny Health Project: A community health promotion programme. Eur Heart J 1995;16:752-5.
28. Doyle F, De La Harpe D, McGee H, et al. Gender differences in the presentation and management of acute coronary syndromes: a national sample of 1365 admissions. Eur J Cardiovasc Prev Rehabil 2005;12:376-9.
29. Williams D, Bennett K, Feely J. Evidence for an age and gender bias in the secondary prevention of ischaemic heart disease in primary care. Br J Clin Pharmacol 2003;55:604-8.
30. Shelley E, Collins C, Daly L. Trends in smoking prevalence: the Kilkenny health project population surveys 1985-1991. Ir Med J 1996;89:183-5.
31. Allwright S, Paul G, Greiner B, et al. Legislation for smoke-free workplaces and health of bar workers in Ireland: before and after study. BMJ 2005;331:1117.
32. McCarthy SN, Gibney MJ, Flynn NA. Irish Universities Nutrition Alliance. Overweight, obesity, and physical activity levels in Irish adults: evidence from North/South Ireland food consumption survey. Proc Nutr Soc 2002;61:3-7.
33. McGovern PG, Jacobs DR,J, Shahar E, et al. Trends in acute coronary heart disease mortality, morbidity and medical care from 1985 through 1997: the Minnesota heart survey. Circulation 2001; 104:19-24.
34. McAlister FA. Commentary: relative treatment effects are consistent across the spectrum of underlying risks, usually. Int J Epidemiol 2002;31:76-7.
35. Fichtenberg C, Glantz S. Association of the California Tobacco Control Program with Declines in Cigarette Consumption and Mortality from Heart Disease. N Engl J Med 2001;343:1772-7.
36. Critchley J, Capewell S. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA 2003;290:86-97.
37. Department of Health and Children. 1999. Building Healthier Hearts Report of the National Cardiovascular Health Strategy, Dublin.
38. Department of Health and Children. Ireland's Changing Heart: Second Report on the Implementation of the Cardiovascular Health Strategy, Dublin, 2003.
39. Department of Health, Ireland: Health Promotion Unit. Available at: http://www.healthpromotion.ie/topics/obesity (accessed 5 December 2005).